Role of p73 in malignancy: tumor suppressor or oncogene?
Open Access
- 25 February 2002
- journal article
- review article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 9 (3) , 237-245
- https://doi.org/10.1038/sj.cdd.4400995
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- p73 is not Mutated in Meningiomas as Determined with a Functional Yeast Assay but p73 Expression Increases with Tumor GradeBrain Pathology, 2001
- Functional characterization of naturally occurring mutants (P405R and P425L) of p73α and p73β found in neuroblastoma and lung cancerOncogene, 2001
- Oncogenes Induce and Activate Endogenous p73 ProteinJournal of Biological Chemistry, 2001
- A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core DomainMolecular and Cellular Biology, 2001
- Enhanced p73 Expression during Differentiation and Complex p73 Isoforms in Myeloid LeukemiaBiochemical and Biophysical Research Communications, 2000
- Analysis of p73 in human borderline and invasive ovarian tumorOncogene, 2000
- E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene productsCell Death & Differentiation, 2000
- Adenovirus‐mediated Transfer of p53‐related Genes Induces Apoptosis of Human Cancer CellsJapanese Journal of Cancer Research, 2000
- Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastomaCell Death & Differentiation, 1999
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994